| Course | NR 586NP Population Health and Epidemiology for Advanced Nursing Practice |
|---|---|
| Week | 8 |
| Paper type | Policy brief |
| Length | About 650 words, 4 pages |
| Format | APA 7 student paper |
| School | Chamberlain University |
| Program | MSN, nurse practitioner core |
| Updated | October 2026 |
Free sample paper for NR 586NP Week 8
Policy Brief: Remove Prior Authorization for Hepatitis C Treatment in the State Medicaid Program for Adults Without Cirrhosis, Addressed to the Medicaid Pharmacy Director
Student Name
College of Nursing, Chamberlain University
NR 586NP: Population Health and Epidemiology for Advanced Nursing Practice
Instructor Name
Month Day, Year
Policy Brief: Remove Prior Authorization for Hepatitis C Treatment in the State Medicaid Program for Adults Without Cirrhosis, Addressed to the Medicaid Pharmacy Director
To, From, Date and Request
To: Pharmacy Director, State Medicaid Program
From: Nurse practitioner student, on behalf of the Hollis County community health center's hepatitis C team
Date: 2 November 2026
Request: Remove prior authorization for pangenotypic direct-acting antiviral treatment for Medicaid adults without cirrhosis, effective 1 July 2027, the start of the state fiscal year.
The Problem as a Rate
At one rural health center in a county with one of the state's highest overdose rates, 43 of every 100 Medicaid patients diagnosed with current hepatitis C in 2025 started treatment within six months. For privately insured patients at the same center, the figure was 71. Nationally, insured adults with Medicaid have also been less likely to start treatment than those with private coverage (Thompson et al., 2022). The difference at this center means about 25 Medicaid patients a year who remain infected and able to pass on the virus, in a county where most new infections are linked to injection drug use.
What the Current Rule Requires
Prior authorization for Medicaid patients requires a fibrosis assessment and a form. For patients in rural counties, the fibrosis assessment often means a hospital visit far away. At the health center, the median time from prescription to approval was 19 days. Each added step loses patients who lack transport or a stable phone.
Options
Option A: remove prior authorization for adults without cirrhosis. Expected effect: Medicaid treatment starts move toward the private rate; the health center estimates its Medicaid rate could rise from 43% to above 60%. Burden: higher drug spending in the first two years, because more patients are treated sooner; the program loses one check on prescribing.
Option B: keep prior authorization but approve automatically within 24 hours with a one-page form and allow a blood-based fibrosis score. Expected effect: smaller, because the form remains a step that staff must complete. Burden: lower spending increase than A; administrative work remains for clinics and the program.
Option C: no change. Expected effect: the current gap persists. Burden: no immediate cost, but continued infections and later costs from liver disease.
Recommendation and Its Trade
Option A. The evidence that nurse practitioners and primary care clinicians can treat most patients safely and effectively (Kattakuzhy et al., 2017) means the check that prior authorization provides adds little for patients without cirrhosis. The trade is plain: the program will spend more on these drugs in the next two years. Several states have managed that cost through fixed-price purchasing agreements with manufacturers, which the program could consider alongside this change.
Why Now
The national recommendation to screen every adult (Schillie et al., 2020) means more Medicaid enrollees are being diagnosed each year. Without a change at the treatment step, the number diagnosed and untreated will grow.
Who Is Worse Off
Other uses of the pharmacy budget compete with the added spending in the short term. The program also gives up a review step that may occasionally catch an inappropriate prescription. Clinics that have built staff roles around prior authorization would need to redeploy that time.
From the Exam Room
A 26-year-old patient at the health center, cured after treatment this year, waited five weeks for approval while living in a car; in that time the patient missed two calls and nearly lost the approval.
How the Effect Would Be Detected
Monthly Medicaid claims for direct-acting antivirals among enrollees with a hepatitis C diagnosis, compared with the same months in the prior year, beginning July 2027.
References
Kattakuzhy, S., Gross, C., Emmanuel, B., Teferi, G., Jenkins, V., Silk, R., Akoth, E., Thomas, A., Ahmed, C., Espinosa, M., Price, A., Rosenthal, E., Tang, L., Wilson, E., Bentzen, S., Masur, H., & Kottilil, S. (2017). Expansion of treatment for hepatitis C virus infection by task shifting to community-based nonspecialist providers: A nonrandomized clinical trial. Annals of Internal Medicine, 167(5), 311-318. https://doi.org/10.7326/M17-0118
Schillie, S., Wester, C., Osborne, M., Wesolowski, L., & Ryerson, A. B. (2020). CDC recommendations for hepatitis C screening among adults: United States, 2020. MMWR Recommendations and Reports, 69(2), 1-17. https://doi.org/10.15585/mmwr.rr6902a1
Thompson, W. W., Symum, H., Sandul, A., Gupta, N., Patel, P., Nelson, N., Mermin, J., & Wester, C. (2022). Vital signs: Hepatitis C treatment among insured adults: United States, 2019-2020. MMWR. Morbidity and Mortality Weekly Report, 71(32), 1011-1017. https://doi.org/10.15585/mmwr.mm7132e1
What the NR 586NP Week 8 assignment asks for
The Week 8 brief is short, addressed and decided. Name a recipient with authority to act, state the problem as a rate a lay reader can hold and reach the request before attention runs out. Include background only where the decision needs it. Offer two or three options, each with an expected effect and what it would ask of someone. Choose one and state the trade plainly, including who is worse off if it goes ahead. Add one short passage only a practitioner could supply. Most rubrics mark down a term paper with a brief's title, a brief addressed to nobody, a costless recommendation and a problem stated as concern rather than a rate.
How the NR 586NP Week 8 example is put together
The sample's header names the Medicaid pharmacy director and asks for removal of prior authorization from 1 July 2027. The problem is 43 of every 100 Medicaid patients treated within six months at one center against 71 for privately insured patients, with national data alongside. The current rule is described in one paragraph. Three options, removing authorization, automatic approval and no change, each carry an effect and a burden. The recommendation names higher drug spending as its trade. A timing note, who is worse off, one line about a patient living in a car and a detection measure using claims close it. Notes in the margin explain the order of the header, the rate and the options.
NR 586NP Week 8 rubric: what full points look like
The characteristic loss is a term paper wearing a brief's title, and this brief makes its request in the opening block. A brief addressed to nobody prevents any judgment of feasibility, while this one names a recipient who controls the rule. A costless recommendation reads as advocacy, so the added spending is stated plainly. A problem stated as concern loses a row, and this one is a rate per 100 patients. Options that are obviously unequal cost marks, and each option here has a real burden. One line from the exam room, kept short, earns the practitioner criterion, and a detection line closes it.
NR 586NP Week 8 help: mistakes that cost points
Weak NR 586NP Week 8 briefs read like research papers, with the recommendation on the last page. Others are addressed to policymakers in general. Many recommend a change without saying what it costs or who loses. Problems are often described as concerning rather than as a rate. Options are sometimes set up so only one is reasonable. Name one person who can act, put your request in the first lines, give each option a real burden and state your trade plainly. If your policy question differs, send the problem rate and the decision maker, and a sample brief can be written for that reader. Read it once as the recipient would, with five minutes to spare.
Get a NR 586NP Week 8 example written to your instructions
Send the brief instructions from your section, the rubric, the word limit and the audience if one is named, and a custom example brief is written to those constraints and returned inside 24-48h. No charge applies to the first one. Where the recipient is left open, the example picks one and defends the choice.
More NR 586NP papers and MSN samples
- NR 586NP Week 1: From Case to Population Post
- NR 586NP Week 2: Community Profile
- NR 586NP Week 3: Rate Calculation Write-Up
- NR 586NP Week 4: Surveillance Data Review
- NR 586NP Week 5: Screening Program Appraisal
- NR 586NP Week 6: Health Disparity Analysis
- NR 586NP Week 7: Population Intervention Plan
- NR 507 Week 8: Synthesis Paper
- NR 585NP Week 8: Dissemination Plan
- NR 509 Week 8: Reflection
- NR 584NP Week 8: Executive Summary
NR 586NP Week 8 questions, answered
How long is a policy brief supposed to be?
Short, and shorter than most drafts. Many sections publish a limit and that limit is doing real work: the format exists because the reader has minutes. Where no ceiling is given, one to two pages with headings, an opening rate and a visible request is the safe shape. Length added past that tends to come out of attention rather than adding to the argument.
What does a practitioner bring that an analyst does not?
A defensible account of what the current position produces at the point of care. That paragraph is short and specific, describing a pattern rather than a person: what gets deferred, who returns later and sicker, which referrals fail. It is evidence of a kind analysts cannot generate, and it works best sitting under a population figure instead of standing in for one.
Is it acceptable to recommend an option with real drawbacks?
It is expected. Every population level change makes somebody worse off, through waiting, through time given up, through reduced choice or through a service moved from one group to reach another. Briefs presenting a recommendation as costless are marked down for exactly that, because a reader who can act already knows the trade exists and stops trusting a document that hides it.
Where can I find a free NR 586NP Week 8 sample paper?
The full policy brief asking a Medicaid pharmacy director to remove prior authorization for hepatitis C treatment is published on this page.
What is the trade in the NR 586NP Week 8 recommendation?
Higher drug spending in the first two years, because more patients are treated sooner, and the loss of one review step on prescribing.